Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

Benzinga · 05/11/2023 06:48
Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and raises the price target from $13.15 to $15.75.